AU2869092A - Heterocyclic 3-phenylpyrrolidin-2-ones, their preparation and use for the manufacture of a medicament for inhibiting tumor necrosis factor production - Google Patents

Heterocyclic 3-phenylpyrrolidin-2-ones, their preparation and use for the manufacture of a medicament for inhibiting tumor necrosis factor production

Info

Publication number
AU2869092A
AU2869092A AU28690/92A AU2869092A AU2869092A AU 2869092 A AU2869092 A AU 2869092A AU 28690/92 A AU28690/92 A AU 28690/92A AU 2869092 A AU2869092 A AU 2869092A AU 2869092 A AU2869092 A AU 2869092A
Authority
AU
Australia
Prior art keywords
phenylpyrrolidin
heterocyclic
medicament
ones
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28690/92A
Inventor
Paul Elliot Bender
Siegfried Benjamin Christensen Iv
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2869092A publication Critical patent/AU2869092A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
AU28690/92A 1991-10-11 1992-10-02 Heterocyclic 3-phenylpyrrolidin-2-ones, their preparation and use for the manufacture of a medicament for inhibiting tumor necrosis factor production Abandoned AU2869092A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US916733 1978-06-19
US77650891A 1991-10-11 1991-10-11
US776508 1991-10-11
US91673392A 1992-07-20 1992-07-20

Publications (1)

Publication Number Publication Date
AU2869092A true AU2869092A (en) 1993-05-03

Family

ID=27119195

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28690/92A Abandoned AU2869092A (en) 1991-10-11 1992-10-02 Heterocyclic 3-phenylpyrrolidin-2-ones, their preparation and use for the manufacture of a medicament for inhibiting tumor necrosis factor production

Country Status (4)

Country Link
AU (1) AU2869092A (en)
MX (1) MX9205875A (en)
PT (1) PT100947A (en)
WO (1) WO1993007141A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665754A (en) * 1993-09-20 1997-09-09 Glaxo Wellcome Inc. Substituted pyrrolidines
ES2139754T3 (en) * 1993-11-26 2000-02-16 Pfizer 3-PHENYL-2-ISOXAZOLINES AS ANTI-INFLAMMATORY AGENTS.
US5612353A (en) * 1995-06-07 1997-03-18 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
ATE360419T1 (en) * 1995-09-19 2007-05-15 Solomon B Margolin USE OF N-SUBSTITUTED PYRIDONES AS TUMOR NECROSIS FACTOR ALPHA INHIBITORS
DE19751062A1 (en) * 1997-11-18 1999-07-08 Univ Ludwigs Albert 4-substituted 2-pyrrolidinone derivatives to reduce extracellular glutamate levels
EP1004578B1 (en) * 1998-11-05 2004-02-25 Pfizer Products Inc. 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
CA2402384A1 (en) 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Ltd. Benzylated pde4 inhibitors
US7056917B2 (en) 2001-04-26 2006-06-06 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor
ATE444065T1 (en) * 2001-10-16 2009-10-15 Memory Pharm Corp 4(4-ALKOXY-3-HYDROXYPHENYL)-2-PYRROLIDONE DERIVATIVES AS PDE-4 INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL SYNDROMES
DE10222024A1 (en) * 2002-05-17 2003-11-27 Bayer Ag New N-substituted N'-((5-oxo-2-pyrrolidinyl)-phenyl)-(thio)ureas, are antiviral agents especially effective against human cytomegalovirus
US7495016B2 (en) 2002-10-21 2009-02-24 Irm Llc Pyrrolidones with anti-HIV activity
DE60326752D1 (en) 2002-11-26 2009-04-30 Pfizer Prod Inc PHENYL SUBTITUED PIPERIDINE COMPOUNDS FOR USE AS PPAR ACTIVATORS
DE10257786A1 (en) * 2002-12-11 2004-07-01 Bayer Healthcare Ag oxazolidinones
KR20060039392A (en) * 2003-04-16 2006-05-08 메모리 파마슈티칼스 코포레이션 Phosphodiesterase 4 inhibitors
EP1631568A1 (en) 2003-04-18 2006-03-08 Memory Pharmaceuticals Corporation Pyrazole derivatives as phosphodiesterase 4 inhibitors
DE602004019814D1 (en) * 2003-12-02 2009-04-16 Ucb Pharma Sa IMIDAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATIONS
AU2005295753A1 (en) 2004-10-15 2006-04-27 Memory Pharmaceuticals Corporation Pyrazole derivatives as phosphodiesterase 4 inhibitors
CN101166737A (en) 2004-10-20 2008-04-23 记忆药物公司 Phosphodiesterase 4 inhibitors
CA2610042C (en) * 2005-06-01 2013-04-23 Ucb Pharma, S.A. 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1350582A (en) * 1970-07-24 1974-04-18 Ucb Sa Cerivatives of 2-pyrrolidinone
JPS5182258A (en) * 1974-04-25 1976-07-19 Yoshitomi Pharmaceutical PIRORIJINON JUDOTAINO SEIZOHO
US4476311A (en) * 1980-03-12 1984-10-09 The Purdue Frederick Company Analgesic 4-carboxy-pyrrolidin-2-one compound
EP0114033B1 (en) * 1982-12-21 1988-10-12 Ciba-Geigy Ag Substituted azabicycloalkanes, their use, pharmaceutical preparations containing these compounds and process for preparing these compounds
FI875101A (en) * 1986-12-03 1988-06-04 Tanabe Seiyaku Co LAKTAMDERIVAT OCH PREPARAT INNEHAOLLANDE DESSA.
DE3823299A1 (en) * 1988-07-07 1990-01-11 Schering Ag SUBSTITUTED PHENYL-PYRROLIDIN-2-ONE, -OXAZOLIDIN-2-ONE AND -IMIDAZOLIDIN-2-ONE, THEIR PRODUCTION AND USE IN MEDICINAL PRODUCTS
DD299058A5 (en) * 1990-01-31 1992-03-26 Arzneimittelwerk Dresden Gmbh,De PROCESS FOR THE PREPARATION OF N-ACYL-4-PHENYL-PYRROLIDIN-2-ONES WITH CEREBROPROTECTIVE EFFECT

Also Published As

Publication number Publication date
PT100947A (en) 1994-02-28
WO1993007141A1 (en) 1993-04-15
MX9205875A (en) 1993-07-01

Similar Documents

Publication Publication Date Title
AU2869092A (en) Heterocyclic 3-phenylpyrrolidin-2-ones, their preparation and use for the manufacture of a medicament for inhibiting tumor necrosis factor production
AU2326892A (en) Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use
AU5112993A (en) Process for the preparation of drug pellets
AU650484B2 (en) Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof
AU6165894A (en) Use of creatine or analogs for the manufacture of a medicament for inhibiting tumor growth
AU626726B2 (en) Uracil derivatives, and their production and use
HU913137D0 (en) 2-amino-4-carboxamido-pirimidine derivatives, their production and medical use
AU4477893A (en) Use of C1-inactivator for the production of a pharmaceutical for the prophylaxis and therapy of certain diseases
AU7269294A (en) Use of glucokinase inhibitors for the manufacture of a medicament for treating tumours
AU3352693A (en) Pyridone derivatives, their preparation and use as medicines
AU5242590A (en) Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions
AU2490492A (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
AU3728095A (en) Use of zaprinast for the manufacture of a medicament for inhibiting vascular restenosis
AU9173191A (en) Medicaments for the treatment of papillomavirus diseases
AU1858992A (en) 2-(1-piperidyl)ethanol derivatives, their preparation and their therapeutic application
AU1116895A (en) Use of theophylline for the manufacture of a medicament for the treatment of asthma
AU3684395A (en) Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
AU668241B2 (en) Condensed heterocyclic compounds, their production and use
AU3904289A (en) Secondary polyetheramines, their production and use for the production of polyureas
AU642772B2 (en) Inhibitors for the formation of tumor necrosis factor, processes for the preparation thereof and the use thereof
AU3144993A (en) Fluorophore-assisted therapeutic drug monitoring
EP0543201A3 (en) Alkoxylated phenyl and coumarin derivatives, their production and use for the manufacture of medicaments
AU2131692A (en) Iminothiazolines, their production and use as herbicides
AU7057691A (en) Piperazine compound, production thereof, and medicinal use thereof
AU1320195A (en) Use of pyridone derivatives as anesthetic drugs